S. Samadi et al. / Tetrahedron: Asymmetry 24 (2013) 269–277
275
(m, 2H), 5.12–5.27 (m, 2H), 7.16–7.59 (m, 16H) 7.97–8.03 (m 2H);
13C NMR (75 MHz, CDCl3): dC (ppm) = 69.9, 75.2, 126.7–130.4 (8C),
141.4, 142.4, 166.1; Minor (S,R,S): 1H NMR (300 MHz, CDCl3): dH
(ppm) = 3.99–4.03 (m, 2H), 4.39–4.55 (m, 2H), 5.12–5.27 (m, 2H),
7.16–7.59 (m, 16H) 7.97–8.03(m. 2H); 13C NMR (75 MHz, CDCl3):
dC (ppm) = 69.7, 74.6, 126.7–130.4 (8C), 141.9, 142.5, 165.4; IR
stirred at room temperature for 3 h. After completion of the reac-
tion as indicated by TLC, only a single new spot (Rf = 0.0 in 50%
EtOAc/n-hexane) was observed.
4.3.1. (S)-2,20-Bis((S)-4-phenyl-4,5-dihydrooxazol-2-yl)-1,10-
biphenyl copper(I) hexafluoro phosphate complex (S,aS,S)-1a-
CuPF6
(KBr, cmꢀ1): 1447, 1646, 2886, 3018, 3065; ½a 2D6
¼ ꢀ179:9 (c
ꢂ
0.50, CHCl3); MS m/z (%): 444 (8, M+), 367(12), 298 (100), 226
(31), 77(42).
1H NMR (300 MHz, CDCl3): dH (ppm) = 3.75–3.80 (t, J = 8.4, 2H),
4.40–4.45 (t, J = 10.0, 2H), 5.13–5.19 (t, J = 9.9, 2H), 6.91–7.77 (m,
18H); 13C NMR (75 MHz, CDCl3): dC (ppm) = 69.8, 74.6, 125.9–
128.4 (6C), 132.2, 136.9, 140.0, 142.7, 169.6; IR (KBr, cmꢀ1): 561,
841, 1086, 1514, 1642, 1688, 2302, 2919, 3740;MS m/z (%): 507
(1, [MꢀPF6]+), 444 (18, M+), 326 (22), 298 (100), 206 (73),
4.2.2. 2,20-Bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)-1,10-
biphenyl (S,S,S)- and (S,R,S)-1b
The 1H NMR of 1b showed two sets of signals: major/minor
(70:30). Rf = 0.15, 0.33 (n-hexane/EtOAc; 40:60); Major (S,S,S): 1H
NMR (300 MHz, CDCl3): dH(ppm) = 2.54–2.68 (m, 2H), 2.95–3.02
(dd, 2H, J 5.2, 13.6 Hz), 3.80–3.90 (m, 2H), 3.97–3.4.03 (t, 2H, J
8.8 Hz), 4.36–4,41 (m, 2H), 7.11–7.53 (m, 16H), 7.81–7.84(d, 2H, J
77(31); ½a 2D6
¼ þ23:4 (c 1, CHCl3).
ꢂ
4.3.2. (S)-2,20-Bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)-1,10-
biphenyl copper(I) hexafluoro phosphate complex (S,aS,S)-1b-
CuPF6
7.4 Hz);13
C NMR (75 MHz, CDCl3): dC(ppm) = 41.3, 67.9, 71.9,
126.3–130.2 (8C), 138.2, 141.4, 164.6; Minor (S,R,S): 1H NMR
(300 MHz, CDCl3): dH (ppm) = 2.54–2.68 (m, 2H), 2.06–3.12 (dd,
2H, J 4.34, 13.6 Hz), 3.80–3.90 (m, 2H), 4.10–4.15 (t, 2H, J 8.8 Hz),
1H NMR (300 MHz, CDCl3): dH(ppm) = 2.30–2.37 (dd, J = 13.6,
8.8, 2H), 2.76–2.83 (dd, 2H, J = 13.6, 5.4 Hz), 3.69–3.74 (t, J = 7.3,
2H), 3.93–3.99 (t, J = 8.8, 2H), 4.26–4.31 (m, 2H), 7.07–7.65 (m,
18H); 13C NMR (75 MHz, CDCl3): dC (ppm) = 35.9, 65.6, 73.8,
124.6, 125.8, 126.8, 127.9, 128.7, 129.2, 130.1, 132.1, 136.4,
137.0, 170.0; IR (KBr, cmꢀ1): 552, 837, 1082, 1546, 1653, 1692,
2316, 2912, 3748;MS m/z (%): 535 (0.7, [MꢀPF6]+), 472 (20, M+),
4.36–4,41 (m, 2H), 7.11–7.53 (m, 16H), 7.88–7.90 (d, 2H,
J
7.3 Hz);13C NMR (75 MHz, CDCl3): dC (ppm) = 41.5, 67.9, 72.0,
126.3–130.2 (8 C), 138.2, 141.6, 164.5; IR (KBr, cmꢀ1): 1501,
1653, 1726, 2913, 3065; MS m/z (%): 472 (11, M+), 382(19), 313
(100), 238 (27), 93(54); ½a D26
ꢂ
¼ ꢀ193:6 (c 0.50, CHCl3).
381(69), 312 (100), 247 (53), 91(62); ½a D26
¼ þ70:8 (c 1, CHCl3).
ꢂ
4.2.3. 2,20-Bis((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)-1,10-
biphenyl (S,S,S)- and (S,R,S)-1c
4.3.3. (S)-2,20-Bis((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)-1,10-
biphenyl copper(I) hexafluoro phosphate complex (S,aS,S)-1c-
CuPF6
The 1H NMR of 1c showed two sets of signals, major/minor
(80:20); Rf = 0.18, 0.5 (n-hexane/EtOAc; 40: 60); Major (S,S,S): 1H
NMR (300 MHz, CDCl3): dH(ppm) = 0.80–0.82 (m, 12H), 1.65–1.74
(m, 2H), 3.74 (t, 2H, J 7.9 Hz), 3.82–3.90 (m, 2H), 4.14 (t, 2H, J
8.7 Hz), 7.22–7.50 (m, 6H), 7.81 (d, 2H, J 7.6 Hz); 13C NMR
(62.5 MHz, CDCl3): dC(ppm) = 18.7, 19.4, 33.3, 69.4, 72.5, 125.8,
127.1, 128.2, 132.3, 136.1, 140.5, 165.4; Minor (S,R,S): 1H NMR
(300 MHz, CDCl3): dH (ppm) = 0.86–0.88(d, 12H, J 6.7 Hz), 1.65–
1.74 (m, 2H), 3.74 (t, 2H, J 7.9 Hz), 3.82–3.90 (m, 2H), 4.14 (t, 2H,
J 8.7 Hz), 7.22–7.50 (m, 6H), 7.86 (d, 2H, J 7.3 Hz); 13C NMR
(62.5 MHz, CDCl3): dC (ppm) = 18.5, 19.0, 33.0, 70.2, 72.7, 126.2,
127.7, 128.1, 132.1, 136.9, 140.2, 165.1; IR (KBr, cmꢀ1): 1467,
1646, 2873, 2959; MS m/z (%): 376 (10, M+), 334(21), 265 (100),
1H NMR (300 MHz, CDCl3): dH(ppm) = 0.66–0.84 (m, 12H), 1.60–
1.90 (m, 2H), 4.31 (br s, 4H), 4.36–4.58 (m, 2H), 7.15–7.42 (m, 6H),
7.61 (br s, 2H); 13C NMR (100 MHz, CDCl3): dC(ppm) = 18.1, 18.6,
32.6, 70.0, 72.4, 126.6, 126.8, 129.9, 131.4, 137.3, 139.7, 167.1; IR
(KBr, cmꢀ1): 552, 771, 843, 1089, 1381,1474, 1638, 1725, 2269,
2965, 3423; MS m/z (%): 439 (0.5, [MꢀPF6]+), 376 (41, M+), 403
(35), 292 (71), 264 (100), 206 (54), 91(34); ½a D26
¼ þ9:2 (c 1, CHCl3).
ꢂ
4.3.4. (S)-2,20-Bis((S)-4-isobutyl-4,5-dihydrooxazol-2-yl)-1,10-
biphenyl copper(I) hexafluoro phosphate complex (S,aS,S)-1d-
CuPF6
1H NMR (300 MHz, CDCl3): 0.95–1.12 (m, 12H), 1.32–1.55 (m,
4H), 1.70–1.71 (m, 2H), 4.23–4.48 (br s, 4H), 4.96 (m, 2H), 7.56
(m, 6H), 7.80–7.83 (d, J = 8.2, 2H).; 13C NMR (75 MHz, CDCl3):
dC(ppm) = 20.8, 22.6, 25.6, 45.8, 65.3, 73.2, 126.8, 127.6, 128.5,
131.7, 137.5, 141.0, 168; IR (KBr, cmꢀ1): 559, 842, 1089,
1381,1467, 1637, 1719, 2276, 2959, 3409; MS m/z (%): 467 (0.5,
[MꢀPF6]+), 403(11, M+), 347(23), 278 (100), 206 (45), 91(37),
191 (26), 43(46); ½a D26
¼ ꢀ157:5 (c 0.50, CHCl3).
ꢂ
4.2.4. 2,20-Bis((S)-4-isobutyl-4,5-dihydrooxazol-2-yl)-1,10-
biphenyl ((S,S,S)- and (S,R,S)-1d
The 1H NMR of 1d showed two sets of signals: major/minor
(63:38). Rf = 0.4, 0.53 (n-hexane/EtOAc; 50:50); Major (S,S,S): 1H
NMR (300 MHz, CDCl3): dH(ppm) = 0.85–0.90 (m, 12H), 1.11–
1.30(m, 2H), 1.42–1.64 (m, 4H), 3.59–3.65 (m, 2H), 4.05–4.23 (m,
55(56); ½a 2D6
¼ þ62:9 (c 1, CHCl3).
ꢂ
4H), 7.23–7.48 (m, 6H), 7.75–7.77 (d,
J
7.9, 2H); 13C NMR
4.4. Synthesis of tert-butyl 4-nitrobenzoperoxoate1n
(62.5 MHz, CDCl3): dC(ppm) = 19.9, 20.3, 33.7, 43.5, 68.1, 76.1,
126.6, 127.1, 128.1, 131.9, 136.5, 139.7, 164.1; Minor (S,R,S): 1H
NMR (300 MHz, CDCl3): dH(ppm) = 0.85–.90 (m, 12H), 1.11–1.30
(m, 2H), 1.42–1.64 (m, 4H), 3.59–3.65 (m, 2H), 4.05–4.23 (m,
p-Nitrobenzoyl chloride (3.2 g, 17.2 mmol) was dissolved in a
100 mL round bottom flask containing CH2Cl2 (35 mL). The solu-
tion was cooled to ꢀ20 °C and stirred under nitrogen for 15 min.
Pyridine (1.7 mL, 20.0 mmol) was then added and the reaction
mixture was stirred for 10 min. Next, tert-butyl hydroperoxide
(3.5 mL, 20.0 mmol) was added dropwise to the reaction at
ꢀ20 °C, and stirred for 4 h. Then the reaction solution was then
diluted with CH2Cl2 (20 mL), and washed with water. The organic
layer was separated, dried over MgSO4, and evaporated to obtain
4H), 7.23–7.48 (m, 6H), 7.82–7.85 (d,
J
7.4, 2H); 13C NMR
(62.5 MHz, CDCl3): dC(ppm) = 20.1, 20.5, 33.2, 43.6, 67.8, 76.2,
126.1, 126.9, 127.7, 131.6, 136.6, 140.2, 163.5; IR (KBr, cmꢀ1):
1461, 1666, 1726, 2926, 2952. MS m/z (%): 404 (4, M+), 347(9),
278 (100), 206 (24), 91(47), 55(37); ½a D26
¼ ꢀ121:4 (c 0.50, CHCl3).
ꢂ
4.3. General procedure for the synthesis of the 1-Cu complex
a
crude yellow solid product. Purification using flash
chromatography (n-hexane/EtOAc; 90:10) afforded a light yellow
solid product. (3.9 g, 98% yield); Mp 75–78 °C. 1H NMR
(300 MHz, CDCl3): dH(ppm) = 1.45 (9H, s, Me), 8.14–8.35 (4H, m,
Ar).
To a solution of ligand 1 (0.02 mmol) in chloroform-d was
added 1 equiv of Cu(I)PF6(CH3CN)4 (0.018 mmol, 6.6 mg,) under
nitrogen atmosphere. The resulting light yellow solution was